QAengineer13
Quite Involved in Discussions
With the new IVDR coming into force, I have a question pertaining to the Legacy IVD products, say if we don't place any new IVD of the legacy model , do we still need to meet all the technical requirement of the IVDR or its only for the products being sold after 2020 (implementation date) we need to meet all the IVDR requirements.
In simple word, for the legacy product already placed in the EU market, do we still need to have a new ER checklist, Clinical evidence etc... as per the IVDR, we are only going to support the already marketed product (no new manufacturing). Any thoughts ?
In simple word, for the legacy product already placed in the EU market, do we still need to have a new ER checklist, Clinical evidence etc... as per the IVDR, we are only going to support the already marketed product (no new manufacturing). Any thoughts ?